WHO plans public web hearings on health, innovation and IP

6 November 2006

All parties with an interest in the upcoming Intergovernmental Working Group on Public Health, Innovation and Intellectual Property are invited to present their views to web-based public hearings organized by the World Health Organization. The WHO says it encourages individuals, civil society groups, government institutions, academic and research institutions, the private sector and other interested parties to contribute to the open hearings between November 1 and 15.

The initiative will provide an opportunity for everyone, including the general public, to contribute to developing a solution to a major public health challenge - how to enhance innovation, R&D to address diseases predominantly affecting poor populations.

The web-based hearings come a few weeks before the start of formal discussions between WHO member states at an Intergovernmental Working Group on Public Health, Innovation and Intellectual Property, taking place in Geneva, Switzerland, on December 4-8. The group will discuss a global strategy and plan of action to enhance R&D to respond to public health challenges. Contributions received November 1-15 will form part of the documentation to be considered and discussed at the December meeting, says the WHO.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight